[Answered] It is not necessary to run dispersion tests and characterize fiber used in core networks. ...

This topic contains a solution. Click here to go to the answer

Author Question: It is not necessary to run dispersion tests and characterize fiber used in core networks. ... (Read 11 times)

vicky

Hero Member
Posts: 586

on: Jul 28, 2018

It is not necessary to run dispersion tests and characterize fiber used in core networks.

Indicate whether the statement is true or false

Question 2

The NDZSF stands for:

A) Number Zero Dispersion Shifted Fiber B) NonDispersion Zero Shifted
C) Nyquist Dispersion Zero Shifted Fiber D) None of the above

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

xoxo123

Sr. Member
Posts: 335

Reply #1 on: Jul 28, 2018

Answer to Question 1

FALSE

Answer to Question 2

B

vicky

Member
Posts: 586

Reply 2 on: Jul 28, 2018

YES! Correct, THANKS for helping me on my review

TheNamesImani

Member
Posts: 334

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.